CD8+ T cell infiltration at the tumor invasive margin, which had been reported to be associated with response to ICI-based therapies31, tended to be increased in these tumors (although the difference was not statistically significant, Mann–Whitney p = 0.14). Here, CD8A is linked to neoplasm.